Effects of WIN 55,212-2 on Excitatory Synaptic Transmission in the Hippocampus
Author Information
Author(s): Németh Beáta, Ledent Catherine, Freund Tamás F., Hájos Norbert
Primary Institution: Institute of Experimental Medicine, Hungarian Academy of Sciences
Hypothesis
How does the synthetic cannabinoid WIN 55,212-2 affect excitatory postsynaptic currents in the hippocampus?
Conclusion
WIN 55,212-2 reduces glutamate release in the hippocampus through both CB1 receptor-dependent and independent mechanisms.
Supporting Evidence
- WIN 55,212-2 reduced the amplitude of EPSCs in a dose-dependent manner.
- The cannabinoid's effect was still significant even when CB1 receptors were blocked.
- WIN 55,212-2's action was mediated through presynaptic mechanisms.
Takeaway
WIN 55,212-2 is a synthetic cannabinoid that can lower the signals between brain cells in the hippocampus, which is important for learning and memory.
Methodology
The study used whole-cell patch-clamp recordings from CA1 pyramidal cells in rat and mouse brain slices to measure the effects of WIN 55,212-2 on excitatory postsynaptic currents.
Participant Demographics
Male Wistar rats (14–18 days old) and wild type and CB1R knockout mice (15–25 days old, CD1 strain) were used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website